Heart Valve Development, Maintenance, and Disease. The Role of Endothelial Cells

Current Topics in Developmental Biology

Volumn 100, Issue , 2012, Pages 203-232

  Tao, Ge ^a   Kotick, James D ^a   Lincoln, Joy ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Blood flow; Endocardial cushion; Endothelial cell; Heart valve; Heart valve disease; Signal transduction

Indexed keywords

EID: 84858766326     PISSN: 00702153     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-387786-4.00006-3     Document Type: Chapter

References (167)

1. Aikawa E., Whittaker P., Farber M., Mendelson K., Padera R.F., Aikawa M., Schoen F.J. Human semilunar cardiac valve remodeling by activated cells from fetus to adult: Implications for postnatal adaptation, pathology, and tissue engineering. Circulation 2006, 113:1344-1352.
2. Aldous I.G., Veres S.P., Jahangir A., Lee J.M. Differences in collagen cross-linking between the four valves of the bovine heart: A possible role in adaptation to mechanical fatigue. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:H1898-H1906.
3. Anderson R.H. Clinical anatomy of the aortic root. Heart 2000, 84:670-673.
4. Anderson R.H., Ho S.Y., Becker A.E. Anatomy of the human atrioventricular junctions revisited. Anat. Rec. 2000, 260:81-91.
5. Bachiller D., Klingensmith J., Shneyder N., Tran U., Anderson R., Rossant J., De Robertis E.M. The role of chordin/Bmp signals in mammalian pharyngeal development and DiGeorge syndrome. Development 2003, 130:3567-3578.
6. Balachandran K., Sucosky P., Yoganathan A.P. Hemodynamics and mechanobiology of aortic valve inflammation and calcification. Int. J. Inflam. 2011, 2011:263870.
7. Bartman T., Walsh E.C., Wen K.K., McKane M., Ren J., Alexander J., Rubenstein P.A., Stainier D.Y. Early myocardial function affects endocardial cushion development in zebrafish. PLoS Biol. 2004, 2:E129.
8. Bartram U., Molin D.G., Wisse L.J., Mohamad A., Sanford L.P., Doetschman T., Speer C.P., Poelmann R.E., Gittenberger-de Groot A.C. Double-outlet right ventricle and overriding tricuspid valve reflect disturbances of looping, myocardialization, endocardial cushion differentiation, and apoptosis in TGF-beta(2)-knockout mice. Circulation 2001, 103:2745-2752.
9. Beppu S., Suzuki S., Matsuda H., Ohmori F., Nagata S., Miyatake K. Rapidity of progression of aortic stenosis in patients with congenital bicuspid aortic valves. Am. J. Cardiol. 1993, 71:322-327.
10. Blevins T.L., Peterson S.B., Lee E.L., Bailey A.M., Frederick J.D., Huynh T.N., Gupta V., Grande-Allen K.J. Mitral valvular interstitial cells demonstrate regional, adhesional, and synthetic heterogeneity. Cells Tissues Organs 2008, 187:113-122.
11. Brunet L.J., McMahon J.A., McMahon A.P., Harland R.M. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 1998, 280:1455-1457.
12. Butcher J.T., Nerem R.M. Valvular endothelial cells regulate the phenotype of interstitial cells in co-culture: Effects of steady shear stress. Tissue Eng. 2006, 12:905-915.
13. Butcher J.T., Nerem R.M. Valvular endothelial cells and the mechanoregulation of valvular pathology. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2007, 362:1445-1457.
14. Butcher J.T., Penrod A.M., Garcia A.J., Nerem R.M. Unique morphology and focal adhesion development of valvular endothelial cells in static and fluid flow environments. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1429-1434.
15. Butcher J.T., Tressel S., Johnson T., Turner D., Sorescu G., Jo H., Nerem R.M. Transcriptional profiles of valvular and vascular endothelial cells reveal phenotypic differences: Influence of shear stress. Arterioscler. Thromb. Vasc. Biol. 2006, 26:69-77.
16. Butcher J.T., McQuinn T.C., Sedmera D., Turner D., Markwald R.R. Transitions in early embryonic atrioventricular valvular function correspond with changes in cushion biomechanics that are predictable by tissue composition. Circ. Res. 2007, 100:1503-1511.
17. Cano A., Perez-Moreno M.A., Rodrigo I., Locascio A., Blanco M.J., del Barrio M.G., Portillo F., Nieto M.A. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2000, 2:76-83.
18. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 380:435-439.
19. Carver E.A., Jiang R., Lan Y., Oram K.F., Gridley T. The mouse snail gene encodes a key regulator of the epithelial-mesenchymal transition. Mol. Cell. Biol. 2001, 21:8184-8188.
20. Chakraborty S., Combs M.D., Yutzey K.E. Transcriptional regulation of heart valve progenitor cells. Pediatr. Cardiol. 2010, 31:414-421.
21. Cho H.J., Baek K.E., Saika S., Jeong M.J., Yoo J. Snail is required for transforming growth factor-beta-induced epithelial-mesenchymal transition by activating PI3 kinase/Akt signal pathway. Biochem. Biophys. Res. Commun. 2007, 353:337-343.
22. Combs M.D., Yutzey K.E. Heart valve development: Regulatory networks in development and disease. Circ. Res. 2009, 105:408-421.
23. Combs M.D., Yutzey K.E. VEGF and RANKL regulation of NFATc1 in heart valve development. Circ. Res. 2009, 105:565-574.
24. Davies P.F. Flow-mediated endothelial mechanotransduction. Physiol. Rev. 1995, 75:519-560.
25. Davies P.F., Barbee K.A., Volin M.V., Robotewskyj A., Chen J., Joseph L., Griem M.L., Wernick M.N., Jacobs E., Polacek D.C., dePaola N., Barakat A.I. Spatial relationships in early signaling events of flow-mediated endothelial mechanotransduction. Annu. Rev. Physiol. 1997, 59:527-549.
26. Davies P.F., Passerini A.G., Simmons C.A. Aortic valve: Turning over a new leaf(let) in endothelial phenotypic heterogeneity. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1331-1333.
27. de la Pompa J.L., Timmerman L.A., Takimoto H., Yoshida H., Elia A.J., Samper E., Potter J., Wakeham A., Marengere L., Langille B.L., Crabtree G.R., Mak T.W. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 1998, 392:182-186.
28. de Lange F.J., Moorman A.F., Anderson R.H., Manner J., Soufan A.T., de Gier-de Vries C., Schneider M.D., Webb S., van den Hoff M.J., Christoffels V.M. Lineage and morphogenetic analysis of the cardiac valves. Circ. Res. 2004, 95:645-654.
29. Deanfield J.E., Halcox J.P., Rabelink T.J. Endothelial function and dysfunction: Testing and clinical relevance. Circulation 2007, 115:1285-1295.
30. Deck J.D. Endothelial cell orientation on aortic valve leaflets. Cardiovasc. Res. 1986, 20:760-767.
31. Delot E.C. Control of endocardial cushion and cardiac valve maturation by BMP signaling pathways. Mol. Genet. Metab. 2003, 80:27-35.
32. Delot E.C., Bahamonde M.E., Zhao M., Lyons K.M. BMP signaling is required for septation of the outflow tract of the mammalian heart. Development 2003, 130:209-220.
33. Devereux R.B., Brown W.T., Kramer-Fox R., Sachs I. Inheritance of mitral valve prolapse: Effect of age and sex on gene expression. Ann. Intern. Med. 1982, 97:826-832.
34. Dimmeler S., Zeiher A.M. Vascular repair by circulating endothelial progenitor cells: The missing link in atherosclerosis?. J. Mol. Med. 2004, 82:671-677.
35. Dor Y., Camenisch T.D., Itin A., Fishman G.I., McDonald J.A., Carmeliet P., Keshet E. A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects. Development 2001, 128:1531-1538.
36. Dor Y., Klewer S.E., McDonald J.A., Keshet E., Camenisch T.D. VEGF modulates early heart valve formation. Anat. Rec. A Discov. Mol. Cell. Evol. Biol. 2003, 271:202-208.
37. Dreger S.A., Taylor P.M., Allen S.P., Yacoub M.H. Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves. J. Heart Valve Dis. 2002, 11:875-880. Discussion 880.
38. Egorova A.D., Van der Heiden K., Van de Pas S., Vennemann P., Poelma C., Deruiter M.C., Goumans M.J., Gittenberger-de Groot A.C., Ten Dijke P., Poelmann R.E., Hierck B.P. Tgfbeta/Alk5 signaling is required for shear stress induced klf2 expression in embryonic endothelial cells. Dev. Dyn. 2011, 240:1670-1680.
39. Eisenberg L.M., Markwald R.R. Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ. Res. 1995, 77:1-6.
40. Eldadah Z.A., Hamosh A., Biery N.J., Montgomery R.A., Duke M., Elkins R., Dietz H.C. Familial Tetralogy of Fallot caused by mutation in the jagged1 gene. Hum. Mol. Genet. 2001, 10:163-169.
41. Fang N.T., Xie S.Z., Wang S.M., Gao H.Y., Wu C.G., Pan L.F. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells. Chin. Med. J. 2007, 120:696-702.
42. Farivar R.S., Cohn L.H., Soltesz E.G., Mihaljevic T., Rawn J.D., Byrne J.G. Transcriptional profiling and growth kinetics of endothelium reveals differences between cells derived from porcine aorta versus aortic valve. Eur. J. Cardiothorac. Surg. 2003, 24:527-534.
43. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., Powell-Braxton L., Hillan K.J., Moore M.W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996, 380:439-442.
44. Frangos S.G., Gahtan V., Sumpio B. Localization of atherosclerosis: Role of hemodynamics. Arch. Surg. 1999, 134:1142-1149.
45. Freeman R.V., Otto C.M. Spectrum of calcific aortic valve disease: Pathogenesis, disease progression, and treatment strategies. Circulation 2005, 111:3316-3326.
46. Galvin K.M., Donovan M.J., Lynch C.A., Meyer R.I., Paul R.J., Lorenz J.N., Fairchild-Huntress V., Dixon K.L., Dunmore J.H., Gimbrone M.A., Falb D., Huszar D. A role for smad6 in development and homeostasis of the cardiovascular system. Nat. Genet. 2000, 24:171-174.
47. Garcia-Martinez V., Sanchez-Quintana D., Hurle J.M. Histochemical and ultrastructural changes in the extracellular matrix of the developing chick semilunar heart valves. Acta Anat. 1991, 142:87-96.
48. Garg V. Insights into the genetic basis of congenital heart disease. Cell. Mol. Life. Sci. 2006, 63:1141-1148.
49. Garg V., Muth A.N., Ransom J.F., Schluterman M.K., Barnes R., King I.N., Grossfeld P.D., Srivastava D. Mutations in NOTCH1 cause aortic valve disease. Nature 2005, 437:270-274.
50. Ge L., Sotiropoulos F. Direction and magnitude of blood flow shear stresses on the leaflets of aortic valves: Is there a link with valve calcification?. J. Biomech. Eng. 2010, 132:014505.
51. Girard P.R., Nerem R.M. Shear stress modulates endothelial cell morphology and F-actin organization through the regulation of focal adhesion-associated proteins. J. Cell. Physiol. 1995, 163:179-193.
52. Gittenberger-de Groot A.C., Vrancken Peeters M.P., Mentink M.M., Gourdie R.G., Poelmann R.E. Epicardium-derived cells contribute a novel population to the myocardial wall and the atrioventricular cushions. Circ. Res. 1998, 82:1043-1052.
53. Grande-Allen K.J., Liao J. The heterogeneous biomechanics and mechanobiology of the mitral valve: Implications for tissue engineering. Curr. Cardiol. Rep. 2011, 13:113-120.
54. Grande-Allen K.J., Griffin B.P., Ratliff N.B., Cosgrove D.M., Vesely I. Glycosaminoglycan profiles of myxomatous mitral leaflets and chordae parallel the severity of mechanical alterations. J. Am. Coll. Cardiol. 2003, 42:271-277.
55. Groenendijk B.C., Hierck B.P., Vrolijk J., Baiker M., Pourquie M.J., Gittenberger-de Groot A.C., Poelmann R.E. Changes in shear stress-related gene expression after experimentally altered venous return in the chicken embryo. Circ. Res. 2005, 96:1291-1298.
56. Groenendijk B.C., Van der Heiden K., Hierck B.P., Poelmann R.E. The role of shear stress on ET-1, KLF2, and NOS-3 expression in the developing cardiovascular system of chicken embryos in a venous ligation model. Physiology 2007, 22:380-389.
57. Gross L., Kugel M.A. Topographic anatomy and histology of the valves in the human heart. Am. J. Pathol. 1931, 7:445-474.
58. Gupta V., Barzilla J.E., Mendez J.S., Stephens E.H., Lee E.L., Collard C.D., Laucirica R., Weigel P.H., Grande-Allen K.J. Abundance and location of proteoglycans and hyaluronan within normal and myxomatous mitral valves. Cardiovasc. Pathol. 2009, 18:191-197.
59. Harrelson Z., Kelly R.G., Goldin S.N., Gibson-Brown J.J., Bollag R.J., Silver L.M., Papaioannou V.E. Tbx2 is essential for patterning the atrioventricular canal and for morphogenesis of the outflow tract during heart development. Development 2004, 131:5041-5052.
60. Helske S., Kupari M., Lindstedt K.A., Kovanen P.T. Aortic valve stenosis: An active atheroinflammatory process. Curr. Opin. Lipidol. 2007, 18:483-491.
61. Hierck B.P., van der Heiden K., DeRuiter M.C., Gittenberger-de Groot A.C., Poelmann R.E. Fluid shear stress controls cardiovascular development. A functionomic approach. Wien. Klin. Wochenschr. 2007, 119:10-13.
62. Hierck B.P., Van der Heiden K., Poelma C., Westerweel J., Poelmann R.E. Fluid shear stress and inner curvature remodeling of the embryonic heart. Choosing the right lane!. The Scientific World Journal 2008, 8:212-222.
63. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 2003, 348:593-600.
64. Hinton R.B., Yutzey K.E. Heart valve structure and function in development and disease. Annu. Rev. Physiol. 2011, 73:29-46.
65. Hinton R.B., Lincoln J., Deutsch G.H., Osinska H., Manning P.B., Benson D.W., Yutzey K.E. Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ. Res. 2006, 98:1431-1438.
66. Hoffman J.I., Kaplan S. The incidence of congenital heart disease. J. Am. Coll. Cardiol. 2002, 39:1890-1900.
67. Hove J.R., Koster R.W., Forouhar A.S., Acevedo-Bolton G., Fraser S.E., Gharib M. Intracardiac fluid forces are an essential epigenetic factor for embryonic cardiogenesis. Nature 2003, 421:172-177.
68. Hurle J.M., Kitten G.T., Sakai L.Y., Volpin D., Solursh M. Elastic extracellular matrix of the embryonic chick heart: An immunohistological study using laser confocal microscopy. Dev. Dyn. 1994, 200:321-332.
69. Hurlstone A.F., Haramis A.P., Wienholds E., Begthel H., Korving J., Van Eeden F., Cuppen E., Zivkovic D., Plasterk R.H., Clevers H. The Wnt/beta-catenin pathway regulates cardiac valve formation. Nature 2003, 425:633-637.
70. Icardo J.M., Colvee E. Atrioventricular valves of the mouse: III. Collagenous skeleton and myotendinous junction. Anat. Rec. 1995, 243:367-375.
71. Jiang X., Rowitch D.H., Soriano P., McMahon A.P., Sucov H.M. Fate of the mammalian cardiac neural crest. Development 2000, 127:1607-1616.
72. Johnson E.N., Lee Y.M., Sander T.L., Rabkin E., Schoen F.J., Kaushal S., Bischoff J. NFATc1 mediates vascular endothelial growth factor-induced proliferation of human pulmonary valve endothelial cells. J. Biol. Chem. 2003, 278:1686-1692.
73. Kokubo H., Tomita-Miyagawa S., Hamada Y., Saga Y. Hesr1 and Hesr2 regulate atrioventricular boundary formation in the developing heart through the repression of Tbx2. Development 2007, 134:747-755.
74. Kopan R., Ilagan M.X. The canonical Notch signaling pathway: Unfolding the activation mechanism. Cell 2009, 137:216-233.
75. Krantz I.D., Piccoli D.A., Spinner N.B. Clinical and molecular genetics of Alagille syndrome. Curr. Opin. Pediatr. 1999, 11:558-564.
76. Kunzelman K.S., Cochran R.P., Murphree S.S., Ring W.S., Verrier E.D., Eberhart R.C. Differential collagen distribution in the mitral valve and its influence on biomechanical behaviour. J. Heart Valve Dis. 1993, 2:236-244.
77. Laforest B., Andelfinger G., Nemer M. Loss of Gata5 in mice leads to bicuspid aortic valve. J. Clin. Invest. 2011, 121:2876-2887.
78. Lange A.W., Yutzey K.E. NFATc1 expression in the developing heart valves is responsive to the RANKL pathway and is required for endocardial expression of cathepsin K. Dev. Biol. 2006, 292:407-417.
79. Leask R.L., Jain N., Butany J. Endothelium and valvular diseases of the heart. Microsc. Res. Tech. 2003, 60:129-137.
80. Lee T.C., Zhao Y.D., Courtman D.W., Stewart D.J. Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase. Circulation 2000, 101:2345-2348.
81. Lehoux S., Castier Y., Tedgui A. Molecular mechanisms of the vascular responses to haemodynamic forces. J. Intern. Med. 2006, 259:381-392.
82. Levay A.K., Peacock J.D., Lu Y., Koch M., Hinton R.B., Kadler K.E., Lincoln J. Scleraxis is required for cell lineage differentiation and extracellular matrix remodeling during murine heart valve formation in vivo. Circ. Res. 2008, 103:948-956.
83. Li L., Krantz I.D., Deng Y., Genin A., Banta A.B., Collins C.C., Qi M., Trask B.J., Kuo W.L., Cochran J., Costa T., Pierpont M.E., et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat. Genet. 1997, 16:243-251.
84. Liebner S., Cattelino A., Gallini R., Rudini N., Iurlaro M., Piccolo S., Dejana E. Beta-catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse. J. Cell Biol. 2004, 166:359-367.
85. Lincoln J., Alfieri C.M., Yutzey K.E. Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos. Dev. Dyn. 2004, 230:239-250.
86. Lincoln J., Alfieri C.M., Yutzey K.E. BMP and FGF regulatory pathways control cell lineage diversification of heart valve precursor cells. Dev. Biol. 2006, 292:292-302.
87. Lincoln J., Lange A.W., Yutzey K.E. Hearts and bones: Shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development. Dev. Biol. 2006, 294:292-302.
88. Lincoln J., Kist R., Scherer G., Yutzey K.E. Sox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve development. Dev. Biol. 2007, 305:120-132.
89. Liu A.C., Joag V.R., Gotlieb A.I. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am. J. Pathol. 2007, 171:1407-1418.
90. Lloyd-Jones D., Adams R.J., Brown T.M., Carnethon M., Dai S., De Simone G., Ferguson T.B., Ford E., Furie K., Gillespie C., Go A., Greenlund K., et al. Heart disease and stroke statistics-2010 update: A report from the American Heart Association. Circulation 2010, 121:e46-e215.
91. Lopez-Sanchez C., Garcia-Martinez V. Molecular determinants of cardiac specification. Cardiovasc. Res. 2011, 91:185-195.
92. Luna-Zurita L., Prados B., Grego-Bessa J., Luxan G., del Monte G., Benguria A., Adams R.H., Perez-Pomares J.M., de la Pompa J.L. Integration of a Notch-dependent mesenchymal gene program and Bmp2-driven cell invasiveness regulates murine cardiac valve formation. J. Clin. Invest. 2010, 120:3493-3507.
93. Lyons K.M., Pelton R.W., Hogan B.L. Organogenesis and pattern formation in the mouse: RNA distribution patterns suggest a role for bone morphogenetic protein-2A (BMP-2A). Development 1990, 109:833-844.
94. Ma L., Martin J.F. Generation of a Bmp2 conditional null allele. Genesis 2005, 42:203-206.
95. Ma L., Lu M.F., Schwartz R.J., Martin J.F. Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. Development 2005, 132:5601-5611.
96. Macgrogan D., Luna-Zurita L., de la Pompa J.L. Notch signaling in cardiac valve development and disease. Birth Defects Res. A Clin. Mol. Teratol. 2011, 91:449-459.
97. Mann B.K., West J.L. Tissue engineering in the cardiovascular system: Progress toward a tissue engineered heart. Anat. Rec. 2001, 263:367-371.
98. Markwald R.R., Norris R.A., Moreno-Rodriguez R., Levine R.A. Developmental basis of adult cardiovascular diseases: Valvular heart diseases. Ann. N. Y. Acad. Sci. 2010, 1188:177-183.
99. Matsumoto Y., Adams V., Walther C., Kleinecke C., Brugger P., Linke A., Walther T., Mohr F.W., Schuler G. Reduced number and function of endothelial progenitor cells in patients with aortic valve stenosis: A novel concept for valvular endothelial cell repair. Eur. Heart J. 2009, 30:346-355.
100. Matzuk M.M., Lu N., Vogel H., Sellheyer K., Roop D.R., Bradley A. Multiple defects and perinatal death in mice deficient in follistatin. Nature 1995, 374:360-363.
101. McDaniell R., Warthen D.M., Sanchez-Lara P.A., Pai A., Krantz I.D., Piccoli D.A., Spinner N.B. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am. J. Hum. Genet. 2006, 79:169-173.
102. Mercado-Pimentel M.E., Runyan R.B. Multiple transforming growth factor-beta isoforms and receptors function during epithelial-mesenchymal cell transformation in the embryonic heart. Cells Tissues Organs 2007, 185:146-156.
103. Miquerol L., Gertsenstein M., Harpal K., Rossant J., Nagy A. Multiple developmental roles of VEGF suggested by a LacZ-tagged allele. Dev. Biol. 1999, 212:307-322.
104. Miquerol L., Langille B.L., Nagy A. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development 2000, 127:3941-3946.
105. Misfeld M., Sievers H.H. Heart valve macro- and microstructure. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2007, 362:1421-1436.
106. Mohler E.R. Are atherosclerotic processes involved in aortic-valve calcification?. Lancet 2000, 356:524-525.
107. Montero J.A., Giron B., Arrechedera H., Cheng Y.C., Scotting P., Chimal-Monroy J., Garcia-Porrero J.A., Hurle J.M. Expression of Sox8, Sox9 and Sox10 in the developing valves and autonomic nerves of the embryonic heart. Mech. Dev. 2002, 118:199-202.
108. Nakajima Y., Yamagishi T., Hokari S., Nakamura H. Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: Roles of transforming growth factor (TGF)-beta and bone morphogenetic protein (BMP). Anat. Rec. 2000, 258:119-127.
109. Nicosia M.A., Cochran R.P., Einstein D.R., Rutland C.J., Kunzelman K.S. A coupled fluid-structure finite element model of the aortic valve and root. J. Heart Valve Dis. 2003, 12:781-789.
110. Niessen K., Fu Y., Chang L., Hoodless P.A., McFadden D., Karsan A. Slug is a direct Notch target required for initiation of cardiac cushion cellularization. J. Cell Biol. 2008, 182:315-325.
111. Nieto M.A. Epithelial-Mesenchymal Transitions in development and disease: Old views and new perspectives. Int. J. Dev. Biol. 2009, 53:1541-1547.
112. Nus M., Macgrogan D., Martinez-Poveda B., Benito Y., Casanova J.C., Fernandez-Aviles F., Bermejo J., de la Pompa J.L. Diet-Induced Aortic Valve Disease in Mice Haploinsufficient for the Notch Pathway Effector RBPJK/CSL. Arterioscler. Thromb. Vasc. Biol. 2011, 31:1580-1588.
113. O'Brien K.D. Epidemiology and genetics of calcific aortic valve disease. J. Investig. Med. 2007, 55:284-291.
114. Oda T., Elkahloun A.G., Pike B.L., Okajima K., Krantz I.D., Genin A., Piccoli D.A., Meltzer P.S., Spinner N.B., Collins F.S., Chandrasekharappa S.C. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat. Genet. 1997, 16:235-242.
115. Oram K.F., Carver E.A., Gridley T. Slug expression during organogenesis in mice. Anat. Rec. A Discov. Mol. Cell. Evol. Biol. 2003, 271:189-191.
116. Otto C.M., Kuusisto J., Reichenbach D.D., Gown A.M., O'Brien K.D. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994, 90:844-853.
117. Paranya G., Vineberg S., Dvorin E., Kaushal S., Roth S.J., Rabkin E., Schoen F.J., Bischoff J. Aortic valve endothelial cells undergo transforming growth factor-beta-mediated and non-transforming growth factor-beta-mediated transdifferentiation in vitro. Am. J. Pathol. 2001, 159:1335-1343.
118. Paruchuri S., Yang J.H., Aikawa E., Melero-Martin J.M., Khan Z.A., Loukogeorgakis S., Schoen F.J., Bischoff J. Human pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in response to vascular endothelial growth factor-A and transforming growth factor-beta2. Circ. Res. 2006, 99:861-869.
119. Passerini A.G., Milsted A., Rittgers S.E. Shear stress magnitude and directionality modulate growth factor gene expression in preconditioned vascular endothelial cells. J. Vasc. Surg. 2003, 37:182-190.
120. Pastor-Perez F., Marin F. Hypertension, aortic sclerosis and the prothrombotic state: Understanding the complex interaction. J. Hum. Hypertens. 2009, 23:287-288.
121. Peacock J.D., Levay A.K., Gillaspie D.B., Tao G., Lincoln J. Reduced sox9 function promotes heart valve calcification phenotypes in vivo. Circ. Res. 2010, 106:712-719.
122. Perez-Pomares J.M., Gonzalez-Rosa J.M., Munoz-Chapuli R. Building the vertebrate heart - an evolutionary approach to cardiac development. Int. J. Dev. Biol. 2009, 53:1427-1443.
123. Person A.D., Klewer S.E., Runyan R.B. Cell biology of cardiac cushion development. Int. Rev. Cytol. 2005, 243:287-335.
124. Plageman T.F., Yutzey K.E. Differential expression and function of Tbx5 and Tbx20 in cardiac development. J. Biol. Chem. 2004, 279:19026-19034.
125. Poggianti E., Venneri L., Chubuchny V., Jambrik Z., Baroncini L.A., Picano E. Aortic valve sclerosis is associated with systemic endothelial dysfunction. J. Am. Coll. Cardiol. 2003, 41:136-141.
126. Rabkin E., Aikawa M., Stone J.R., Fukumoto Y., Libby P., Schoen F.J. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 2001, 104:2525-2532.
127. Rabkin-Aikawa E., Mayer J.E., Schoen F.J. Heart valve regeneration. Adv. Biochem. Eng. Biotechnol. 2005, 94:141-179.
128. Rajamannan N.M., Gersh B., Bonow R.O. Calcific aortic stenosis: From bench to the bedside-Emerging clinical and cellular concepts. Heart 2003, 89:801-805.
129. Rajamannan N.M., Subramaniam M., Rickard D., Stock S.R., Donovan J., Springett M., Orszulak T., Fullerton D.A., Tajik A.J., Bonow R.O., Spelsberg T. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 2003, 107:2181-2184.
130. Ranger A.M., Grusby M.J., Hodge M.R., Gravallese E.M., de la Brousse F.C., Hoey T., Mickanin C., Baldwin H.S., Glimcher L.H. The transcription factor NF-ATc is essential for cardiac valve formation. Nature 1998, 392:186-190.
131. Rivera-Feliciano J., Tabin C.J. Bmp2 instructs cardiac progenitors to form the heart-valve-inducing field. Dev. Biol. 2006, 295:580-588.
132. Romano L.A., Runyan R.B. Slug is an essential target of TGFbeta2 signaling in the developing chicken heart. Dev. Biol. 2000, 223:91-102.
133. Rutenberg J.B., Fischer A., Jia H., Gessler M., Zhong T.P., Mercola M. Developmental patterning of the cardiac atrioventricular canal by Notch and Hairy-related transcription factors. Development 2006, 133:4381-4390.
134. Sacks M.S., David Merryman W., Schmidt D.E. On the biomechanics of heart valve function. J. Biomech. 2009, 42:1804-1824.
135. Sales V.L., Mettler B.A., Engelmayr G.C., Aikawa E., Bischoff J., Martin D.P., Exarhopoulos A., Moses M.A., Schoen F.J., Sacks M.S., Mayer J.E. Endothelial progenitor cells as a sole source for ex vivo seeding of tissue-engineered heart valves. Tissue Eng. Part A 2010, 16:257-267.
136. Sanford L.P., Ormsby I., Gittenberger-de Groot A.C., Sariola H., Friedman R., Boivin G.P., Cardell E.L., Doetschman T. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 1997, 124:2659-2670.
137. Santhanakrishnan A., Miller L.A. Fluid Dynamics of Heart Development. Cell Biochem Biophys. 2011, 61(1):1-22.
138. Schoen F.J. Aortic valve structure-function correlations: Role of elastic fibers no longer a stretch of the imagination. J. Heart Valve Dis. 1997, 6:1-6.
139. Schoen F.J. Evolving concepts of cardiac valve dynamics: The continuum of development, functional structure, pathobiology, and tissue engineering. Circulation 2008, 118:1864-1880.
140. Schroeder J.A., Jackson L.F., Lee D.C., Camenisch T.D. Form and function of developing heart valves: Coordination by extracellular matrix and growth factor signaling. J. Mol. Med. 2003, 81:392-403.
141. Scott M., Vesely I. Aortic valve cusp microstructure: The role of elastin. Ann. Thorac. Surg. 1995, 60:S391-S394.
142. Sehnert A.J., Huq A., Weinstein B.M., Walker C., Fishman M., Stainier D.Y. Cardiac troponin T is essential in sarcomere assembly and cardiac contractility. Nat. Genet. 2002, 31:106-110.
143. Simmons C.A., Grant G.R., Manduchi E., Davies P.F. Spatial heterogeneity of endothelial phenotypes correlates with side-specific vulnerability to calcification in normal porcine aortic valves. Circ. Res. 2005, 96:792-799.
144. Somi S., Buffing A.A., Moorman A.F., Van Den Hoff M.J. Dynamic patterns of expression of BMP isoforms 2, 4, 5, 6, and 7 during chicken heart development. Anat. Rec. A Discov. Mol. Cell. Evol. Biol. 2004, 279:636-651.
145. Sorescu G.P., Sykes M., Weiss D., Platt M.O., Saha A., Hwang J., Boyd N., Boo Y.C., Vega J.D., Taylor W.R., Jo H. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress stimulates an inflammatory response. J. Biol. Chem. 2003, 278:31128-31135.
146. Sorrentino S.A., Bahlmann F.H., Besler C., Muller M., Schulz S., Kirchhoff N., Doerries C., Horvath T., Limbourg A., Limbourg F., Fliser D., Haller H., et al. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: Restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation 2007, 116:163-173.
147. Sridurongrit S., Larsson J., Schwartz R., Ruiz-Lozano P., Kaartinen V. Signaling via the Tgf-beta type I receptor Alk5 in heart development. Dev. Biol. 2008, 322:208-218.
148. Stamatas G.N., McIntire L.V. Rapid flow-induced responses in endothelial cells. Biotechnol. Prog. 2001, 17:383-402.
149. Stankunas K., Ma G.K., Kuhnert F.J., Kuo C.J., Chang C.P. VEGF signaling has distinct spatiotemporal roles during heart valve development. Dev. Biol. 2010, 347:325-336.
150. Stein P.D., Wang C.H., Riddle J.M., Sabbah H.N., Magilligan D.J., Hawkins E.T. Scanning electron microscopy of operatively excised severely regurgitant floppy mitral valves. Am. J. Cardiol. 1989, 64:392-394.
151. Stewart B.F., Siscovick D., Lind B.K., Gardin J.M., Gottdiener J.S., Smith V.E., Kitzman D.W., Otto C.M. Clinical factors associated with calcific aortic valve disease. Cardiovascular health study. J. Am. Coll. Cardiol. 1997, 29:630-634.
152. Sultana N., Nag K., Hoshijima K., Laird D.W., Kawakami A., Hirose S. Zebrafish early cardiac connexin, Cx36.7/Ecx, regulates myofibril orientation and heart morphogenesis by establishing Nkx2.5 expression. Proc. Natl. Acad. Sci. USA 2008, 105:4763-4768.
153. Supino P.G., Borer J.S., Yin A., Dillingham E., McClymont W. The epidemiology of valvular heart diseases: The problem is growing. Adv. Cardiol. 2004, 41:9-15.
154. Tanaka K., Sata M., Fukuda D., Suematsu Y., Motomura N., Takamoto S., Hirata Y., Nagai R. Age-associated aortic stenosis in apolipoprotein E-deficient mice. J. Am. Coll. Cardiol. 2005, 46:134-141.
155. Tao G., Levay A.K., Gridley T., Lincoln J. Mmp15 is a direct target of Snai1 during endothelial to mesenchymal transformation and endocardial cushion development. Dev. Biol. 2011, 359:209-221.
156. Thubrikar M.J., Aouad J., Nolan S.P. Patterns of calcific deposits in operatively excised stenotic or purely regurgitant aortic valves and their relation to mechanical stress. Am. J. Cardiol. 1986, 58:304-308.
157. Thubrikar M.J., Nolan S.P., Aouad J., Deck J.D. Stress sharing between the sinus and leaflets of canine aortic valve. Ann. Thorac. Surg. 1986, 42:434-440.
158. Timmerman L.A., Grego-Bessa J., Raya A., Bertran E., Perez-Pomares J.M., Diez J., Aranda S., Palomo S., McCormick F., Izpisua-Belmonte J.C., de la Pompa J.L. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev. 2004, 18:99-115.
159. Todorovic V., Finnegan E., Freyer L., Zilberberg L., Ota M., Rifkin D.B. Long form of latent TGF-beta binding protein 1 (Ltbp1L) regulates cardiac valve development. Dev. Dyn. 2011, 240:176-187.
160. Venkatesh D.A., Park K.S., Harrington A., Miceli-Libby L., Yoon J.K., Liaw L. Cardiovascular and hematopoietic defects associated with Notch1 activation in embryonic Tie2-expressing populations. Circ. Res. 2008, 103:423-431.
161. Vermot J., Forouhar A.S., Liebling M., Wu D., Plummer D., Gharib M., Fraser S.E. Reversing blood flows act through klf2a to ensure normal valvulogenesis in the developing heart. PLoS Biol. 2009, 7:e1000246.
162. Wang H., Goland S., Burton K., Czer L.S., Schwarz E.R., Trento A. An agonist of liver X receptor slows valvular disease in a hypercholesterolemia mouse model. J. Heart Valve Dis. 2010, 19:653-664.
163. Ward C. Clinical significance of the bicuspid aortic valve. Heart 2000, 83:81-85.
164. Weiss R.M., Ohashi M., Miller J.D., Young S.G., Heistad D.D. Calcific aortic valve stenosis in old hypercholesterolemic mice. Circulation 2006, 114:2065-2069.
165. Werner N., Kosiol S., Schiegl T., Ahlers P., Walenta K., Link A., Bohm M., Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 2005, 353:999-1007.
166. Wu B., Wang Y., Lui W., Langworthy M., Tompkins K.L., Hatzopoulos A.K., Baldwin H.S., Zhou B. Nfatc1 coordinates valve endocardial cell lineage development required for heart valve formation. Circ. Res. 2011, 109:183-192.
167. Zhou B., von Gise A., Ma Q., Hu Y.W., Pu W.T. Genetic fate mapping demonstrates contribution of epicardium-derived cells to the annulus fibrosis of the mammalian heart. Dev. Biol. 2010, 338:251-261.